Literature DB >> 19009075

Target-selective photo-degradation of HIV-1 protease by a fullerene-sugar hybrid.

Shuho Tanimoto1, Satoshi Sakai, Shuichi Matsumura, Daisuke Takahashi, Kazunobu Toshima.   

Abstract

A designed fullerene-sugar hybrid effectively and selectively degraded the target protein, HIV-1 protease, which has high affinity for the fullerene moiety; degradation was achieved using long-wavelength UV or visible photo-irradiation, in the absence of any additives and under neutral conditions.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19009075     DOI： 10.1039/b811726h

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN： 1359-7345            Impact factor:   6.222


  6 in total

1.  Fullerene Derivatives Strongly Inhibit HIV-1 Replication by Affecting Virus Maturation without Impairing Protease Activity.

Authors:  Zachary S Martinez; Edison Castro; Chang-Soo Seong; Maira R Cerón; Luis Echegoyen; Manuel Llano
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

Review 2.  Design and creativity in synthesis of multivalent neoglycoconjugates.

Authors:  Yoann M Chabre; René Roy
Journal:  Adv Carbohydr Chem Biochem       Date:  2010       Impact factor: 12.200

Review 3.  Emerging nanotechnology approaches for HIV/AIDS treatment and prevention.

Authors:  Tewodros Mamo; E Ashley Moseman; Nagesh Kolishetti; Carolina Salvador-Morales; Jinjun Shi; Daniel R Kuritzkes; Robert Langer; Ulrich von Andrian; Omid C Farokhzad
Journal:  Nanomedicine (Lond)       Date:  2010-02       Impact factor: 5.307

4.  Cell Internalization Studies of Gadofullerene-(ZME-018) Immunoconjugates into A375m Melanoma Cells.

Authors:  Christopher Scott Berger; John W Marks; Robert D Bolskar; Michael G Rosenblum; Lon J Wilson
Journal:  Transl Oncol       Date:  2011-12-01       Impact factor: 4.243

5.  Computational studies of the binding mechanisms of fullerenes to human serum albumin.

Authors:  Jinyu Li; Lizhi Jiang; Xiaolei Zhu
Journal:  J Mol Model       Date:  2015-06-21       Impact factor: 1.810

6.  Fullerenemalonates inhibit amyloid beta aggregation, in vitro and in silico evaluation.

Authors:  Martínez-Herrera Melchor; Figueroa-Gerstenmaier Susana; García-Sierra Francisco; Beltrán Hiram I; Rivera-Fernández Norma; Lerma-Romero Jorge A; López-Camacho Perla Y; Basurto-Islas Gustavo
Journal:  RSC Adv       Date:  2018-11-27       Impact factor: 4.036
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.